Axq Capital »

Abcellera Biologics shares owned by Axq Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Axq Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $124k 27k 4.60

More positions owned by Axq Capital

Advanced Micro Devices (AMD)
Boeing Company (BA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Centene Corporation (CNC)
Honeywell International (HON)
Deere & Company (DE)
Lauder Estee Cos Cl A (EL)
Dell Technologies CL C (DELL)
Costco Wholesale Corporation (COST)
Archer Daniels Midland Company (ADM)
Wells Fargo & Company (WFC)
Snowflake Cl A (SNOW)
Blackstone Group Inc Com Cl A (BX)
Datadog Cl A Com (DDOG)

View all positions for Axq Capital

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics